Apr 26, 2021

FDA to scrutinize unproven cancer drugs after 10-year gap

Posted by in category: biotech/medical

The U.S. spends more per person on prescription drugs than any other nation, and spending on cancer drugs has more than doubled since 2013 to over $60 billion annually, according to the data firm IQVIA. New medications typically cost $90000 to $300000 a year. And those prices have risen much faster than patient survival.

Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.

Comments are closed.